Le Lézard
Classified in: Health
Subjects: PDT, FDA, SBS

Enexor Ventilators Granted FDA Emergency Use Authorization


FRANKLIN, Tenn., June 17, 2020 /PRNewswire/ --  Enexor Health Systems announced today that the U.S. Food and Drug Administration (FDA) has granted an Emergency Use Authorization for the immediate delivery and use of a new ventilator, the X-VENT. Enexor will start delivering ventilators to hospitals within a few days.

Guided by the medical team of physicians and respiratory therapists, led by Dr. Bill Walsh of Vanderbilt University's Monroe Carrol Jr Children's Hospital, a pioneer in ventilation technology and one of the design team members of the original oscillating  ventilator, the X-VENT was designed to deliver the critical modes of ventilations required for COVID patients.  "The X-VENT is a sophisticated, complex, state-of the-art ventilator capable of providing multiple modes of mechanical ventilation. The engineers did an amazing job keeping it simple, easy to use and inexpensive. It is exactly what the physicians of the world need to support their patients through acute respiratory failure." states Dr. Bill Walsh.

The X-VENT is one of the very few FDA EUA approved ventilators that does not use a bag valve mask (BVM) resuscitator (often referred to colloquially by the proprietary name "Ambu-bag").  The X-VENT utilizes a piston driven air system controlled by a Schneider Electric industrial-grade programmable logic computer (PLC). The system is designed for many years of use, and is self-calibrating, so it can easily be stored.  The X-VENT is priced significantly below the cost of a traditional ventilator to encourage world-wide use to impact more lives.

Enexor has leveraged its extensive engineering design, manufacturing, and operational capabilities to quickly design, test and manufacture the unique ventilator.  "Enexor was created to help solve major world problems. In responding to COVID and future pandemics, we stayed true to our mission by putting together an incredible team of medical professionals, engineers and manufacturing specialists with the ultimate mission of designing and manufacturing a durable, reliable, easy to maintain, and affordable ventilator that can be deployed at any hospital in the world to help save lives.  The team delivered with the X-VENT.", states Jestings.

Enexor has already begun manufacturing ventilators. With the FDA approval, Enexor will ramp up manufacturing to meet the critical needs in the U.S. and internationally. 

About Enexor Health Systems
Enexor Health Systems, a wholly-owned subsidiary of Enexor Energy, LLC, manufactures life-saving medical equipment for hospitals throughout the world.  Enexor manufactures the X-VENT critical care ventilator which combines the precision and independence of a piston-driven ventilation system to deliver a comprehensive set of ventilation modes and settings to meet patients' needs. The self-calibrating piston technology minimizes maintenance required making it the ideal ventilation storage device for current and future pandemics. The X-VENT has received FDA Emergency Use Authorization (EUA) approval. Enexor manufactures its systems at its headquarters in Franklin, Tennessee, a Nashville suburb.www.EnexorHealth.com

Media Contact
Ty Kelley
Marketing & Communications
[email protected]
615-942-2674

SOURCE Enexor Health Systems


These press releases may also interest you

at 20:31
Fitness International, LLC opened a new Club Studio location in Kingwood, Texas. The new 40,000 square foot club features five innovative boutique fitness studios that were carefully curated to create a unique experience, along with recovery services...

at 19:35
Mirum Pharmaceuticals, Inc. today announced that on May 10, 2024, the Compensation Committee of Mirum's Board of Directors granted inducement awards consisting of non-qualified stock options to purchase 38,600 shares of common stock and 19,300...

at 19:00
Evolus, Inc. , a performance beauty company with a focus on building an aesthetic portfolio of consumer brands, today reported the grant of non-qualified stock options to purchase an aggregate of 10,990 shares of Evolus and an aggregate of 42,759...

at 18:36
Inhibrx, Inc. ("Inhibrx," or the "Company") today announced that in connection with the previously announced distribution by the Company of 92% of shares of common stock of its subsidiary Inhibrx Biosciences, Inc. ("SpinCo") to holders of shares of...

at 17:55
Asia Green Biotechnology Corp. ("Asia Green" or the "Company") announces that, further to its news releases dated April 17, 2024, April 26, 2024, and May 8, 2024, the Management Cease Trade Order ("MCTO") issued by the...

at 17:53
The following statement is being issued by Rice Harbut Elliott LLP regarding the Ruckman v. Biotrade Canada Ltd. et al. lawsuit: All persons in Canada who purchased or ingested U-Dream on or after August 18, 2014 (the "Class" or "Class Members")...



News published on and distributed by: